Cadence Alternative Investments

Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.

7 partners are named across this firm’s filings, 7 of them on a fund it is deploying now.

Classified sectors of Cadence Alternative Investments’s own portfolio companies, based on 6 with a verified or cited source.

• Biotech & pharma3 · 50%
• Data & analytics1 · 17%
• Media & creator tools1 · 17%
• Medical devices1 · 17%

Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Cadence Alternative Investments’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.